Daniel S. Johnston, Ph.D.

Daniel S. Johnston earned his Ph.D. from The Johns Hopkins University Bloomberg School of Public Health and conducted postdoctoral studies at Washington State University. He spent almost 10 years at the pharmaceutical company Wyeth/Pfizer, where he led projects focused on early stage drug discovery for contraception and developed translational research expertise in the therapeutic areas of women’s health and oncology. Between 2010 and 2016, Daniel worked as Vice President of Pharmaceutical Research for Delcath Systems and as Director of Preclinical Research and Development at Cellphire, Inc. In 2016, Daniel moved to the NICHD, where he is chief of the Contraception Research Branch.